Hosted on MSN
Why is Plus Therapeutics stock gaining Friday?
Plus Therapeutics Inc. PSTV shares are up on Friday on continuous momentum after the company announced that the U.S. Food and Drug Administration (FDA) on Wednesday granted Orphan Drug Designation for ...
We recently published Massive Gains: 10 Stocks Investors Can’t Stop Buying. Plus Therapeutics Inc. (NASDAQ:PSTV) is one of the top performers on Thursday. Shares of Plus Therapeutics soared by 39.29 ...
Fintel reports that on November 3, 2025, HC Wainwright & Co. maintained coverage of Plus Therapeutics (NasdaqCM:PSTV) with a Buy recommendation. As of October 30, 2025, the average one-year price ...
Fintel reports that on October 31, 2025, D. Boral Capital maintained coverage of Plus Therapeutics (NasdaqCM:PSTV) with a Buy recommendation. As of October 30, 2025, the average one-year price target ...
Plus Therapeutics (PSTV) shares plunged 35% premarket after the healthcare company launched an offering of 39.47M units to raise around $15M in proceeds. Each unit consists of one share of common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results